natgillin/translations-raw huggingface dataset:
VPRIV не повлиява или повлиява пренебрежимо способността за шофиране и работа с машини.
VPRIV has no or negligible influence on your ability to drive or use machines.
VPRIV се предлага във флакон под формата на сбит прах, който преди интравенозната инфузия се смесва с вода за инжекции и след това се разрежда с разтвор на натриев хлорид 9 mg/ml (0,9%).
VPRIV is supplied in a vial as a packed powder which is mixed with sterile water and further diluted in sodium chloride 9 mg/ml (0.9%) solution prior to intravenous infusion.
VR: ваксинален отговор
(262; 580)
VR: ваксинален отговор
VR: vaccine response tested at GSK laboratories
Vracanie (stupeň 3-4 = 6,5 %), nauzea (stupeň 3-4 = 6 %),
Vomiting (Grade 3-4 = 6.5%), Nausea (Grade 3-4 = 6%),
Vrednost AUC0-12 za oteracil v azijski skupini je približno ustrezala polovici primerljive vrednosti v kavkaški skupini, vendar ta razlika zaradi velike individualne variabilnosti ni bila statistično značilna.
Oteracil AUC0-12 in the Asian group was approximately half that of the Caucasian group, however, this difference was not statistically significant due to its large individual variability.
Vrednost CrCl je treba izračunati na začetku posameznega cikla, in sicer na 1. dan pred začetkom zdravljenja z zdravilom Teysuno.
CrCl must be calculated at the beginning of every cycle before the start of treatment with Teysuno on Day 1.
Vrednost p
p-value
vrednost pc
p-valuec
Vrednosti AUC0-12 za gimeracil in uracil so bile primerljive med skupinama, kar pomeni, da je bilo zaviranje DPD-ja v azijski in kavkaški skupini podobno.
Gimeracil and uracil AUC0-12 values were comparable between the two groups, suggesting that DPD inhibition was similar for the Asian and Caucasian groups.
Vrednosti za tegafur, gimeracil, oteracil in 5-FU so bile izmerljive 10 ur po odmerku.
Levels of tegafur, gimeracil, oteracil and 5-FU were quantifiable through 10 hours postdose.
Vrnite ga distributerju/proizvajalcu.
Return to distributor / manufacturer
Vrojene, dedne in genetske okvare
Congenital and familial and genetic disorders
Vrojene, dedne in genetske okvare
Congenital, and familial and genetic disorders
vročina bolečina na mestu infuzije.
fever pain at the site of infusion
vročina,
fever
vročina,
fever,
Vročina.
Fever.
Vrsta organskega sistema
System organ class
Vrsta ovojnine in vsebina
Nature and composition of immediate packaging
Vrsta ovojnine in vsebina
Nature and contents of container
Vrsta ovojnine in vsebina
Nature and contents of container‌‌‌‌‌
Vrste neželenih učinkov v tej populaciji so bile podobne tistim pri odraslih z napredovalimi malignimi boleznimi, ki zajamejo kosti (glejte poglavje 4.8).
The type of adverse reactions observed in this population were similar to those previously seen in adults with advanced malignancies involving the bone (see section 4.8).
vrtoglavica
Vertigo
Vsak izraz je prikazan samo v kategoriji, ki je zanj najbolj značilna; znotraj vsake skupine pogostnosti pa so neželeni učinki navedeni po padajoči resnosti.
Each term is presented in its most common category only and within each frequency grouping, adverse reactions are presented in order of decreasing seriousness.
Vsak ml vsebuje:
Each ml contains:
Vsak odmerek rekonstituiranega cepiva vsebuje:
Each dose of reconstituted vaccine contains:
vsak pojav
Any occurrence
Vsaka kapsula ima belo neprosojno telo z belim neprosojnim pokrovčkom in odtisom "TC442" v sivi barvi.
The capsule has an opaque white body and opaque white cap imprinted “TC442” in grey.
Vsaka kapsula ima belo neprosojno telo z rjavim neprosojnim pokrovčkom in odtisom "TC448" v sivi barvi.
The capsule has an opaque white body and opaque brown cap imprinted “TC448” in grey.
Vsaka trda kapsula vsebuje 15 mg tegafurja, 4,35 mg gimeracila in 11,8 mg oteracila (v obliki monokalija).
Each hard capsule contains 15 mg tegafur, 4.35 mg gimeracil, and 11.8 mg oteracil (as monopotassium).
Vsaka trda kapsula vsebuje 20 mg tegafurja, 5,8 mg gimeracila in 15,8 mg oteracila (v obliki monokalija).
Each hard capsule contains 20 mg tegafur, 5.8 mg gimeracil, and 15.8 mg oteracil (as monopotassium).
Vsaka viala vsebuje 1 mg topotekana (v obliki topotekanijevega klorida) v 1 ml koncentrata.
Each vial contains 1 mg topotecan (as hydrochloride) in 1 ml concentrate.
Vsaka viala vsebuje 4 mg topotekana (v obliki topotekanijevega klorida) v 4 ml koncentrata.
Each vial contains 4 mg topotecan (as hydrochloride) in 4 ml concentrate.
Vsaka škatla vsebuje 42 kapsul, 84 kapsul ali 126 kapsul.
Each pack contains either 42 capsules, 84 capsules or 126 capsules.
Vsako neporabljeno zdravilo ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisi.
Any unused veterinary medicinal product or waste material derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Vsako neporabljeno zdravilo ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisi.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Vsako neporabljeno zdravilo ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisi.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with the local requirements.
Vsako neporabljeno zdravilo ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisi.
Any unused veterinary product or waste material derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Vsako neporabljeno zdravilo ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisi.
Any unused veterinary product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Vsako neporabljeno zdravilo ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi zahtevami.
Any unused veterinary product or waste material derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Vsako neporabljeno zdravilo za uporabo v veterinarski medicini ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisi.
Any unused veterinary medicinal product or waste material derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Vsako neporabljeno zdravilo za uporabo v veterinarski medicini ali odpadne snovi, ki nastanejo iz teh zdravil, je treba odstraniti v skladu z lokalnimi predpisi.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
Vsako pakiranje vsebuje 42 kapsul ali 84 kapsul.
Each pack contains 42 capsules or 84 capsules.
Vsako pakiranje vsebuje 42 kapsul, 84 kapsul ali 126 kapsul.
Each pack contains either 42 capsules, 84 capsules or 126 capsules.
Vsako pakiranje vsebuje eno vialo s 100 mg, 500 mg ali 1.000 mg pemetrekseda (v obliki dinatrijevega pemetrekseda hemipentahidrata).
Each pack contains one vial of 100 mg, 500 mg or 1,000 mg pemetrexed as (pemetrexed disodium hemipentahydrate)
Vse bolnike so spremljali do 52 tednov po prvem prejemu proučevanega zdravila.
All patients were followed for up to 52 weeks following first administration of study treatment.
Vse bolnike so spremljali do 76 tednov po prvem prejemu preučevanega zdravila.
All patients were followed for up to 76 weeks following first administration of study treatment.
Vse bolnike, še posebno pa bolnike, starejše od 60 let, bolnike, ki so dolgo časa prejemali imunosupresive ali tiste, ki so prejemali zdravljenje s PUVA, je treba spremljati zaradi možnosti pojava nemelanomskega kožnega raka (glejte poglavje 4.8).
All patients, in particular those greater than 60 years of age, patients with a medical history of prolonged immunosuppressant therapy or those with a history of PUVA treatment, should be monitored for the appearance of non-melanoma skin cancer (see section 4.8).
Vse jakosti Pramipeksol Accord tablet je možno dobiti v aluminijastih pretisnih omotih po 10 tablet na enem traku, v škatlah ki vsebujejo 3 ali 10 pretisne omote (30 ali 100 tablet).
All the strengths of Pramipexole Accord tablets are available in alu-alu blisters of 10 tablets per strip, in cartons containing 3 or 10 blister strips (30 or 100 tablets).
Vse jeklenke morate vrniti dobavitelju, da jih bo odstranil.
All gas cylinders should be returned to the supplier for disposal.
Vse pripomočke, ki jih potrebujete pri dajanju zdravila ali čiščenju, tudi rokavice, morate odvreči v vreče za shranjevanje nevarnih odpadkov, ki so namenjene sežigu pri visokih temperaturah
All items for administration or cleaning, including gloves, should be placed in high-risk, waste disposal bags for high-temperature incineration.
Vse pripomočke, ki jih potrebujete pri dajanju zdravila ali čiščenju, tudi rokavice, morate odvreči v vreče za shranjevanje nevarnih odpadkov, ki so namenjene sežigu pri visokih temperaturah.
All items for administration or cleaning, including gloves, should be placed in high-risk, waste disposal bags for high-temperature incineration.
Vse študije so izvedli z bolniki z rakom.
All studies were performed in cancer patients.
vsebina (koncentracija)
Strength
Vsebina kapsule laktoza monohidrat, mikrokristalna celuloza, askorbilpalmitat, povidon K29-32,
Cellulose microcrystalline Ascorbyl palmitate Povidone K29-32
vsebina kapsule: laktoza monohidrat, mikrokristalna celuloza, askorbilpalmitat, povidon, natrijev karboksimetilškrob, magnezijev stearat, smukec, triacetin, natrijev hidrogenkarbonat, lauroil makrogolgliceridi, hidroksipropilceluloza, makrogol 20 000. ovoj kapsul: želatina, indigotin (E132), črni železov oksid (E172), titanov dioksid (E171), rumeni železov oksid (E172).
capsule content: lactose monohydrate, cellulose microcrystalline, ascorbyl palmitate, povidone, sodium starch glycolate, magnesium stearate, talc, triacetin, sodium hydrogen carbonate, lauroyl macrogolglycerides, hydroxypropylcellulose, macrogol 20 000. capsule shell: gelatine, indigo carmine (E132), black iron oxide (E172), titanium dioxide (E171), yellow iron oxide (E172).
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo INOmax
Contents of the pack and other information What INOmax contains
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Palonosetron Hospira
Contents of the pack and other information What Palonosetron Hospira contains
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Pemetreksed Hospira Zdravilna učinkovina je pemetreksed.
Contents of the pack and other information What Pemetrexed Hospira contains
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Pramipeksol Accord Zdravilna učinkovina je pramipeksol.
Contents of the pack and other information What Pramipexole Accord tablet contains:
VSEBINA PAKIRANJA IN DODATNE INFORMACIJE Kaj vsebuje zdravilo Pravafenix
Contents of the pack and other information What Pravafenix contains
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Stelara
Contents of the pack and other information What Stelara contains
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Teysuno
Contents of the pack and other information What Teysuno contains
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Topotekan Teva
Contents of the pack and other information What Topotecan Teva contains
Vsebina pakiranja in dodatne informacije Kaj vsebuje zdravilo Zoledronska kislina Actavis
Contents of the pack and other information What Zoledronic acid Actavis contains
Vsebina pakiranja in odatne informacije
Contents of the pack and other information
VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ENOT
CONTENTS BY WEIGHT, BY VOLUME OR BY UNIT
VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ODMERKOV
CONTENTS BY WEIGHT, BY VOLUME OR BY NUMBER OF DOSES
VSEBINA, IZRAŽENA Z MASO, PROSTORNINO ALI ŠTEVILOM ODMERKOV
CONTENTS BY WEIGHT, BY VOLUME OR NUMBER OF DOSES
Vsebnik zdravila vsebuje gumo.
The container of this medicinal product contains latex rubber.
Vsebuje dvodimenzionalno črtno kodo z edinstveno oznako.
2D barcode carrying the unique identifier included.
Vsebuje laktozo monohidrat.
Contains lactose monohydrate
Vsebuje laktozo monohidrat.
Contains lactose monohydrate.
Vsebuje manitol, natrijev citrat in vodo za injekcije.
PHARMACEUTICAL FORM AND CONTENTS
Vsebuje tudi dušik.
Also contains nitrogen.
Vseeno so klopidogrel in acetilsalicilno kislino sočasno uporabljali do enega leta (glejte poglavje 5.1).
However, clopidogrel and ASA have been administered together for up to one year (see section 5.1).
Vseeno za sedaj nimamo na voljo zadostne količine podatkov, da bi priporočili odmerek za to skupino bolnikov.
However there are insufficient data available to make a dose recommendation for this patient group.
Vsega skupaj 493 pediatričnih bolnikov, starih od 64 dni do 16,9 let, ki so prejemali zmerno (69,2 %) ali visoko emetogeno kemoterapijo (30,8 %), so zdravili s palonosteronom 10 µg/kg (največji odmerek 0,75 mg), palonosetronom 20 µg/kg (največji odmerek 1,5 mg) ali ondansetronom (3 x 0,15 mg/kg , največji celotni odmerek 32 mg) 30 minut pred začetkom emetogene kemoterapije med ciklom 1.
A total of 493 paediatric patients, aged 64 days to 16.9 years, receiving moderately (69.2%) or highly emetogenic chemotherapy (30.8%) were treated with palonosetron 10 μg/kg (maximum 0.75 mg), palonosetron 20 μg/kg (maximum 1.5 mg) or ondansetron (3 x 0.15 mg/kg , maximum total dose 32 mg) 30 minutes prior to the start of emetogenic chemotherapy during Cycle 1.
Vsi bolniki so imeli diagnozo nedrobnoceličnega pljučnega karcinoma IIIB ali IV. stopnje in so predhodno prejemali kemoterapijo na osnovi platine.
All patients were diagnosed with Stage IIIB or IV NSCLC and had received prior platinum-based chemotherapy.
Vsi bolniki, vključeni v to študijo, so imeli ECOG status učinka 0 ali 1.
All patients included in this study had an ECOG performance status 0 or 1.
Vsi glavni presnovki so farmakološko neaktivni.
All major metabolites have been shown to be pharmacologically inactive.
Vsi primeri striktur bi naj bili povezani z zdravljenjem, od tega je 1% veljal za hude.
All incidences of strictures were considered associated with treatment of which 1% was considered serious.‌‌
Vsi vključeni bolniki v tej študiji so imeli ECOG status učinka 0 ali 1.
All patients included in this study had an ECOG performance status 0 or 1.
Vso neporabljeno raztopino je treba zavreči.
Any unused solution should be discarded.
Vss (ml/kg) Средно ± SD
Vss (mL/kg) Mean ± SD
Vstřebávání
Absorption
Vt lõik 4.
See section 4.
VTEp и VTEt - Не се налага корекция на дозата (вж. точки 4.4 и 5.2).
VTEp and VTEt - No dose adjustment required (see sections 4.4 and 5.2).
VTEp и VTEt -Не се налага корекция на дозата (вж. точки 4.4 и 5.2).
VTEp and VTEt – No dose adjustment required (see sections 4.4 and 5.2).
VTEt – Не се налага корекция на дозата (вж. точки 4.4 и 5.2).
VTEt - No dose adjustment required (see sections 4.4 and 5.2).
VTEt –Не се налага корекция на дозата (вж. точки 4.4 и 5.2).
VTEt - No dose adjustment required (see sections 4.4 and 5.2).
Vuxna med njurinsufficiens
Adults with renal insufficiency
Vuxna och ungdomar från 12 till < 18 år med en kroppsvikt på ≥ 33 kg: se tabell 1.
Adults and adolescents aged from 12 to < 18 years with bodyweight ≥ 33 kg: see Table 1.
Vuxna: Din läkare kommer att tala om för dig vilken mängd Emtriva oral lösning som skall tas.
Adults: Your doctor will advise the correct amount of Emtriva oral solution to be taken.
Vuxna: en 200 mg hård kapsel om dagen med eller utan mat.
Adults: one 200 mg hard capsule each day with or without food.
Vuxna: Rekommenderad dos av Emtriva 10 mg/ml oral lösning är 240 mg (24 ml) en gång dagligen.
Adults: The recommended dose of Emtriva 10 mg/ml oral solution is 240 mg (24 ml) once daily.
Vuxna: Rekommenderad dos av Emtriva är en hård kapsel à 200 mg som tas oralt en gång dagligen.
Adults: The recommended dose of Emtriva is one 200 mg hard capsule, taken orally, once daily.
VWF води до отложена във времете корекция на асоциирания дефицит на FVIII.
VWF produces delayed correction of the associated FVIII deficiency.
VWF води до отложена във времето корекция на асоциирания дефицит на FVIII.
VWF produces delayed correction of the associated FVIII deficiency.
VWF възстановява адхезията на тромбоцитите към съдовия субендотел на мястото на увреждането на съда (като се свързва, както към съдовия субендотел, така и към тромбоцитната мембрана), осигурявайки първична хемостаза, доказана чрез скъсяване на времето на кървене.
VWF re-establishes platelet adhesion to the vascular sub-endothelium at the site of vascular damage (as it binds both to the vascular sub-endothelium and to the platelet membrane), providing primary haemostasis as shown by the shortening of the bleeding time.
Vybírejte si jídla, která obsahují celou škálu různých živin, a naučte se dlouhodobě jíst zdravě.
You should choose meals which contain a range of different nutrients and learn to eat healthily for the long term.
Vyhněte se souběžnému podávání přípravku EVOTAZ a rivaroxabanu.
Avoid concomitant use of EVOTAZ and rivaroxaban.
Vylaer Spiromax budesonide/formoterol
Vylaer Spiromax budesonide / formoterol
Vylaer Spiromax е „хибридно лекарство“.
Vylaer Spiromax is a ‘hybrid medicine’.
Vylaer Spiromax се използва също за облекчаване на симптомите на тежка хронична обструктивна белодробна болест (ХОББ) при възрастни, които са имали екзацербации (изостряния) на заболяването в миналото въпреки редовната терапия.
Vylaer Spiromax is also used to relieve the symptoms of severe chronic obstructive pulmonary disease (COPD) in adults who have had exacerbations (flare–ups) of the disease in the past despite regular treatment.
Vylučovanie trabektedínu do mlieka u zvierat sa neskúmalo.
The excretion of trabectedin in milk has not been studied in animals.
Vyndaqel 20 mg меки капсули тафамидис меглумин (tafamidis meglumine)
Vyndaqel 20 mg soft capsules
Vyndaqel е разрешен за употреба при „извънредни обстоятелства“.
Vyndaqel has been authorised under ‘exceptional circumstances’.
Vyndaqel се използва за отлагане на неврологично увреждане, причинено от транстиретинова амилоидоза — наследствено заболяване, при което в тъканите на организма, включително около нервите, се натрупват нишки, наречени амилоиди.
Vyndaqel is used to delay nerve damage caused by transthyretin amyloidosis, a hereditary disease in which fibres called amyloid build up in tissues around the body including around the nerves.
Vyndaqel спрямо плацебо: NIS-LL и TQOL на месец 18 (проучване Fx-005)
Vyndaqel versus Placebo: NIS-LL and TQOL at Month 18 (Study Fx-005)
Vynechaná dávka
Missed dose
Vyrážka
Rash
Vyrážka a s ní spojené syndromy
Rash and associated syndromes
Vyrážky
Rash
Vyrážky jsou obvykle mírné až středně závažné makulopapulární kožní exantémy, které se objevují během prvních 3 týdnů od zahájení terapie atazanavirem, který je složkou přípravku EVOTAZ.
Rashes are usually mild-to-moderate maculopapular skin eruptions that occur within the first 3 weeks of starting therapy with atazanavir, a component of EVOTAZ.
Vyrážky jsou obvykle mírné až středně závažné makulopapulární kožní exantémy, které se objevují během prvních 3 týdnů od zahájení terapie atazanavirem.
Rashes are usually mild-to-moderate maculopapular skin eruptions that occur within the first 3 weeks of starting therapy with atazanavir.
Vysoké Mýto Чешка Република
Vysoké Mýto Czech Republic
Vysoký krevní tlak
High blood pressure
Vyšetrenia elektrokardiogramu (ECG)
Electrocardiogram (ECG) investigations
Vyšetření
Investigations
Vyšší
Higher
Vyžaduje si ďalšie riedenie a je iba na jednorazové použitie.
It requires further dilution and is for single-use only
Vyžaduje si ďalšie riedenie a je iba na jednorazové použitie.
It requires further dilution and is for single-use only.
Vzdrževalno zdravljenje:
Maintenance treatment
Vzdělávací materiály (včetně kontrolního seznamu pro předepisující lékaře) pouze pro zdravotnické pracovníky
Educational material (including prescriber checklist) for the healthcare professionals
Vzdělávací materiály a kontrolní seznam pro předepisující lékaře musí obsahovat následující klíčové body:
The Educational material and Prescriber checklist shall contain the following key messages:
vzdělávací terapii, sociální terapii.
educational therapy social therapy
Vzemite brizgo in snemite pokrovček z igle.
Pick up the syringe and remove the needle cover
Vzhledem k účinku přípravku Intuniv na srdeční frekvenci se souběžné užití přípravku Intuniv s léčivými přípravky prodlužujícími QT interval obecně nedoporučuje (viz bod 4.4).
Given the effect of Intuniv on heart rate, the concomitant use of Intuniv with QT prolonging medicinal products is generally not recommended (see section 4.4).
VZV-специфичните имунни отговори към двете ваксини 4 седмици след ваксинирането са подобни както при едновременно, така и при самостоятелно приложение.
The VZV-specific immune responses to both vaccines at 4 weeks postvaccination were similar, whether administered concomitantly or nonconcomitantly.
VZV-специфичният имунен отговор е като цяло подобен при участници на възраст 50-59 години в сравнение с тези на възраст ≥ 60 години.
VZV- specific immune responses were generally similar in subjects 50 to 59 compared to subjects ≥60 years of age.
VZV-специфичният имунен отговор към ваксината 6 седмици след ваксинирането, е сравним при групите с приложена бустер доза и първа доза.
The VZV-specific immune responses to vaccine 6 weeks postvaccination was comparable in the booster dose and first dose group.
VZV–специфичният имунен отговор след Доза 1 и 2 е сходен (вж. точка 4.3).
The VZV specific immune responses following Doses 1 and 2 were similar (see section 4.3).
Vzácné
common
Vzácné
rare
Vzácné
uncommon
Vzácné (mohou postihnout více než 1 z 1 000 osob) prodloužení QTc (nepravidelný srdeční tep)
Rare (may affect up to 1 in 1,000 people)
Vzácné nežádoucí účinky (vyskytující se u 1 až 10 pacientů z 10 000): závratě
Rare side effect (affects 1 to 10 patients in 10,000): Vertigo.
Vzácné: mohou postihnout až 1 osobu z 1000
Rare: may affect up to 1 in 1,000 people
Vzájemné působení s dalšími léčivými přípravky
Taking other medicines:
VÄLISPAKENDIL PEAVAD OLEMA JÄRGMISED ANDMED
PARTICULARS TO APPEAR ON THE OUTER PACKAGING
VÝROBCA ZODPOVEDNÝ ZA UVOĽNENIE ŠARŽE
MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
VÝROBCE ODPOVĚDNÝ ZA PROPOUŠTĚNÍ ŠARŽÍ
MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
VÝROBCE ODPOVĚDNÝ ZA PROPOUŠTĚNÍ ŠARŽÍ‌‌‌
MANUFACTURER RESPONSIBLE FOR BATCH RELEASE‌‌‌
VÝROBCE ODPOVĚDNÝ/VÝROBCI ODPOVĚDNÍ ZA PROPOUŠTĚNÍ ŠARŽÍ
MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE
VÝROBCE ODPOVĚDNÝ/VÝROBCI ODPOVĚDNÍ ZA PROPOUŠTĚNÍ ŠARŽÍ
MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE‌‌‌
VÝROBCI ODPOVĚDNI ZA PROPOUŠTĚNÍ ŠARŽÍ
MANUFACTURING AUTHORISATION HOLDERS RESPONSIBLE FOR BATCH RELEASE
Váci ut 91
Qormi QRM 3217
Váha
Weight
vám je méně než 18 let.
if you are under 18 years old.
Váš lekár vám oznámi, ako dlho vaša liečba trvá.
Your doctor will tell you how long your treatment lasts.
Váš lékař vám doporučí, která kombinace těchto léků s přípravkem EVOTAZ je pro vás nejlepší.
Your doctor will discuss with you which combination of these medicines with EVOTAZ is best for you.
Váš lékař vám vysvětlí případný přínos a rizika léčby přípravkem EVOTAZ pro vás a pro vaše dítě.
Your doctor will discuss the potential benefits and risks of taking EVOTAZ to you and your child.
Vänta och ta nästa dos vid dess ordinarie tidpunkt.
Wait and take the next dose at the regular time.
vävnad
tissue disorders
Väčšina hodnôt sa znížila na stupeň 1 alebo vymizla do dňa 14-15 (pozri časť 4.4).
Most of the values had decreased to grade 1 or resolved by day 14-15 (see section 4.4).